FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.10  |  FHIR Version n/a  User: [n/a]

4653311000001104: Simeticone 125mg / Loperamide 2mg chewable tablets 18 tablet (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
21278101000001116 Simeticone 125mg / Loperamide 2mg chewable tablets 18 tablet (product) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module
21278201000001111 Simeticone 125mg / Loperamide 2mg chewable tablets 18 tablet en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module

1 descendants. Search Descendants:

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Simeticone 125mg / Loperamide 2mg chewable tablets 18 tablet Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Simeticone 125mg / Loperamide 2mg chewable tablets 18 tablet Is a Virtual medicinal product pack true Inferred relationship Existential restriction modifier
Simeticone 125mg / Loperamide 2mg chewable tablets 18 tablet Is pack of Product containing precisely dimeticone (as simeticone) 125 milligram and loperamide hydrochloride 2 milligram/1 each conventional release chewable tablet false Inferred relationship Existential restriction modifier
Simeticone 125mg / Loperamide 2mg chewable tablets 18 tablet Has active ingredient Loperamide false Inferred relationship Existential restriction modifier
Simeticone 125mg / Loperamide 2mg chewable tablets 18 tablet Has active ingredient Simeticone false Inferred relationship Existential restriction modifier
Simeticone 125mg / Loperamide 2mg chewable tablets 18 tablet VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Simeticone 125mg / Loperamide 2mg chewable tablets 18 tablet VMP non-availability indicator Not available true Inferred relationship Existential restriction modifier
Simeticone 125mg / Loperamide 2mg chewable tablets 18 tablet Has manufactured dose form Conventional release oral tablet false Inferred relationship Existential restriction modifier
Simeticone 125mg / Loperamide 2mg chewable tablets 18 tablet Has VMP Product containing precisely dimeticone (as simeticone) 125 milligram and loperamide hydrochloride 2 milligram/1 each conventional release chewable tablet true Inferred relationship Existential restriction modifier
Simeticone 125mg / Loperamide 2mg chewable tablets 18 tablet Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Dimeticone true Inferred relationship Existential restriction modifier
Simeticone 125mg / Loperamide 2mg chewable tablets 18 tablet Has specific active ingredient Loperamide hydrochloride true Inferred relationship Existential restriction modifier
Simeticone 125mg / Loperamide 2mg chewable tablets 18 tablet Has specific active ingredient Simeticone true Inferred relationship Existential restriction modifier
Simeticone 125mg / Loperamide 2mg chewable tablets 18 tablet Has dispensed dose form Conventional release chewable tablet true Inferred relationship Existential restriction modifier
Simeticone 125mg / Loperamide 2mg chewable tablets 18 tablet Has basis of strength substance Dimeticone true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Imodium Plus chewable tablets (McNeil Ltd) 18 tablet 3 x 6 tablets Is a True Simeticone 125mg / Loperamide 2mg chewable tablets 18 tablet Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start